• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    OneSource Specialty Pharma Ltd.
    11 Jun 2025
    1873.30
    -0.33%
    OneSource Specialty Pharma partners with Swedish biotech company Xbrane, on its biosimilar portfolio
    Business Line
    As part of the agreement, Xbrane will undertake a tech-transfer of its commercial product to OneSource's integrated drug substance and drug product facility in Bengaluru
    Copy LinkShare onShare on Share on Share on
    OneSource Specialty Pharma Ltd. has gained 30.00% in the last 6 Months
    logo
    Marksans Pharma Ltd.
    11 Jun 2025
    168.91
    -1.56%
    Marksans Pharma shares surge 5% after block trades; details here
    Business Standard
    Marksans Pharma shares rose 5 per cent after 10.27 million shares changed hands via multiple pre-market block trades
    Copy LinkShare onShare on Share on Share on
    Marksans Pharma Ltd. has lost -21.71% in the last 1 Month
    logo
    Sun Pharmaceutical Industries Ltd.
    11 Jun 2025
    1593.60
    0.71%
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    'Buy' Sun Pharma Shares Maintains Nirmal Bang, Says India, Specialty To Drive Growth
    NDTV Profit
    Nirmal Bang maintains Buy rating underpinned by Sun Pharma's strong positioning as a unique play on both the India branded market and the global specialty pharma opportunity.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below all available SMAs
    logo
    OneSource Specialty Pharma Ltd.
    10 Jun 2025
    1873.30
    -0.33%
    Mukul Agrawal portfolio stock hits record high; zooms 75% from March low
    Business Standard
    Shares of OneSource Specialty Pharma hit a new high of 2,031.45 in Tuesday's intra-day trade in otherwise a subdued market and rallied 28% in the past month
    Copy LinkShare onShare on Share on Share on
    OneSource Specialty Pharma Ltd. has gained 30.00% in the last 6 Months
    logo
    Glenmark Pharmaceuticals Ltd.
    10 Jun 2025
    2051.90
    3.06%
    Glenmark Pharma rises 2% as company to launch blood cancer treatment drug
    Business Standard
    Glenmark Pharma shares gained 2 per cent in trade as company announced the upcoming launch of zanubrutinib, under the brand name Brukinsa in India
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
    logo
    Dr. Reddy's Laboratories Ltd.
    07 Jun 2025, 07:23PM
    1268.10
    1.21%
    Dr. Reddy's Laboratories: Holding on to a sweet promise
    Business Line
    The transition from Revlimid led growth to diabetes portfolio will be rocky yet rewarding
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
    logo
    Wockhardt Ltd.
    05 Jun 2025, 09:54PM
    1478.80
    0.20%
    Wockhardt's New Antibiotic Zaynich Targets $7-Billion US, Europe Market
    Wockhardt's New Antibiotic Zaynich Targets $7-Billion US, Europe Market
    NDTV Profit
    The company plans to file for USFDA approval in the second quarter of the current financial year.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 171 to 186 in Jun 2025 qtr.
    Wockhardt files for regulatory approval of novel antibiotic Zaynich
    Business Line | 05 Jun 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    05 Jun 2025
    1268.10
    1.21%
    Alvotech, Dr Reddy's ink pact to co-develop Biosimilar for cancer treatment
    Business Line
    Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd.'s price crossed above 50Day SMA today
    Dr Reddy's, Alvotech to co-develop biosimilar of cancer drug Keytruda
    Business Standard | 05 Jun 2025 4 more
    Dr Reddy's, Alvotech Partner To Develop Biosimilar For Cancer Treatment
    NDTV Profit | 05 Jun 2025
    Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment
    Business Standard | 05 Jun 2025
    Alvotech, Dr Reddy's partner to develop Keytruda Biosimilar
    Business Line | 05 Jun 2025
    Dr Reddy's Labs rallies 4%, hits over four-month high; here's why
    Business Standard | 05 Jun 2025
    logo
    Glenmark Pharmaceuticals Ltd.
    05 Jun 2025
    2051.90
    3.06%
    Stocks to buy today, June 5: Glenmark Pharma, M&M among analyst top picks
    Business Standard
    Stocks to buy today, June 5: Analyst at Religare Broking has recommended buying Glenmark Pharma, M&M and one more stock with upside potential
    Copy LinkShare onShare on Share on Share on
    Deven Choksey increased Buy price target of Glenmark Pharmaceuticals Ltd. to 2300.0 on 02 Sep, 2025.
    logo
    Ipca Laboratories Ltd.
    04 Jun 2025
    1335.00
    -0.31%
    Broker's call: Ipca Lab (Add)
    Business Line
    InCred Equities
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 294 to 270 in Jun 2025 qtr
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd